Estrogen receptor β induces antiinflammatory and antitumorigenic networks in colon cancer cells

Molecular Endocrinology

Volumn 25, Issue 6, 2011, Pages 969-979

  Edvardsson, Karin ^a   Ström, Anders ^a   Jonsson, Philip ^a   Gustafsson, Jan Åke ^b   Williams, Cecilia ^b  

^a University of Houston   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR BETA; INTERLEUKIN 6; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PROX1; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL CYCLE; COLON CANCER; CONTROLLED STUDY; DNA REPAIR; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DEDIFFERENTIATION; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; COLONIC NEOPLASMS; DNA DAMAGE; ESTROGEN RECEPTOR BETA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENOME-WIDE ASSOCIATION STUDY; HOMEODOMAIN PROTEINS; HUMANS; INFLAMMATION MEDIATORS; MODELS, GENETIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 79957667295     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2010-0452     Document Type: Article

References (64)

1. Grodstein F, Newcomb PA, Stampfer MJ 1999 Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 106:574-582
2. Newcomb PA, Zheng Y, Chia VM, Morimoto LM, Doria-Rose VP, Templeton A, Thibodeau SN, Potter JD 2007 Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women. Cancer Res 67:7534-7539
3. Park BW, Kim KS, Heo MK, Ko SS, Hong SW, Yang WI, Kim JH, Kim GE, Lee KS 2003 Expression of estrogen receptor-β in normal mammary and tumor tissues: is it protective in breast carcinogenesis? Breast Cancer Res Treat 80:79-85
4. Pasquali D, Staibano S, Prezioso D, Franco R, Esposito D, Notaro A, De Rosa G, Bellastella A, Sinisi AA 2001 Estrogen receptor β expression in human prostate tissue. Mol Cell Endocrinol 178: 47-50
5. Rutherford T, Brown WD, Sapi E, Aschkenazi S, Mun ̃oz A. Mor G. 2000 Absence of estrogen receptor-beta expression in metastatic ovarian cancer. Obstet Gynecol 96:417-421
6. Hartman J, Lindberg K, Morani A, Inzunza J, Ström A. Gustafsson JA. 2006 Estrogen receptor β inhibits angiogenesis and growth of T47D breast cancer xenografts. Cancer Res 66:11207-11213
7. Murphy LC, Peng B, Lewis A, Davie JR, Leygue E, Kemp A, Ung K, Vendetti M, Shiu R 2005 Inducible upregulation of oestrogen receptor-β1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells. J Mol Endocrinol 34:553-566
8. Ström A, Hartman J, Foster JS, Kietz S, Wimalasena J, Gustafsson JA. 2004 Estrogen receptor_inhibits 17βestradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci USA 101:1566-1571
9. Chang EC, Frasor J, Komm B, Katzenellenbogen BS 2006 Impact of estrogen receptorβon gene networks regulated by estrogen receptorβin breast cancer cells. Endocrinology 147:4831-4842
10. Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL, Leitman DC 2004 Estrogen receptor_ inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 64:423-428
11. Williams C, Edvardsson K, Lewandowski SA, Ström A, Gustafsson JA 2008 A genome-wide study of the repressive effects of estrogen receptorβon estrogen receptorβsignaling in breast cancer cells. Oncogene 27:1019-1032
12. Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andricopoulos P, Varakis I, Sotiropoulou-Bonikou G, Papavassiliou AG 2003 Oestrogen receptorβ(ER_) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer 39:1251-1258
13. Jassam N, Bell SM, Speirs V, Quirke P 2005 Loss of expression of oestrogen receptor_ in colon cancer and its association with Dukes' staging. Oncol Rep 14:17-21
14. Nü ssler NC, Reinbacher K, Shanny N, Schirmei ́er A, Glanemann M, Neuhaus P, Nussler AK, Kirschner M 2008 Sex-specific differences in the expression levels of estrogen receptor subtypes in colorectal cancer. Gend Med 5:209-217
15. Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O, Rice LW 2000 Selective loss of estrogen receptorβin malignant human colon. Cancer Res 60:245-248
16. Giroux V, Lemay F, Bernatchez G, Robitaille Y, Carrier JC 2008 Estrogen receptorβdeficiency enhances small intestinal tumorigenesis in ApcMin/_ mice. Int J Cancer 123:303-311
17. Giroux V, Bernatchez G, Carrier JC 2011 Chemopreventive effect of ERβselective agonist on intestinal tumorigenesis in Apc(Min/+) mice. Mol Carcinog 50:359-369
18. Deroo BJ, Buensuceso AV 2010 Minireview: Estrogen receptorβ: mechanistic insights from recent studies. Mol Endocrinol 24:1703-1714
19. Hartman J, Edvardsson K, Lindberg K, Zhao C, Williams C, Ström A, Gustafsson JA. 2009 Tumor repressive functions of estrogen receptorβin SW480 colon cancer cells. Cancer Res 69:6100-6106
20. Milanini-Mongiat J, Pouysse ́gur J, Pages G. 2002 Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: their implication in vascular endothelial growth factor gene transcription. J Biol Chem 277:20631-20639
21. Förster C, Mäkela S, Wärri A, Kietz S, Becker D, Hultenby K, Warner M, Gustafsson JA 2002 Involvement of estrogen receptorβin terminal differentiation of mammary gland epithelium. Proc Natl Acad Sci USA 99:15578-15583
22. Zhao C, Gao H, Liu Y, Papoutsi Z, Jaffrey S, Gustafsson JA, Dahlman-Wright K 2010 Genome-wide mapping of estrogen receptor- βbinding regions reveals extensive cross-talk with transcription factor activator protein-1. Cancer Res 70:5174-5183
23. Rayoo M, Yan M, Takano EA, Bates GJ, Brown PJ, Banham AH, Fox SB 2009 Expression of the forkhead box transcription factor FOXP1 is associated with oestrogen receptor β, oestrogen receptor β and improved survival in familial breast cancers. J Clin Pathol 62:896-902
24. Petrova TV, Nykänen A, Norrme ́n C, Ivanov KI, Andersson LC, Haglund C, Puolakkainen P, Wempe F, von Melchner H, Gradwohl G, Vanharanta S, Aaltonen LA, Saharinen J, Gentile M, Clarke A, Taipale J, Oliver G, Alitalo K 2008 Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype. Cancer Cell 13:407-419
25. Charest-Marcotte A, Dufour CR, Wilson BJ, Tremblay AM, Eichner LJ, Arlow DH, Mootha VK, Giguere V 2010 The homeobox protein Prox1 is a negative modulator of ERRα/PGC-1α bioenergetic functions. Genes Dev 24:537-542
26. Thomas CG, Strom A, Lindberg K, Gustafsson JA 10 July 2010 Estrogen receptorβdecreases survival of p53-defective cancer cells after DNA damage by impairing G(2)/M checkpoint signaling. Breast Cancer Res Treat 10.1007/s10549-010-1011-z
27. Byun DS, Chae KS, Ryu BK, Lee MG, Chi SG 2002 Expression and mutation analyses of P53R2, a newly identified p53 target for DNA repair in human gastric carcinoma. Int J Cancer 98:718-723
28. Parsons R, Li GM, Longley MJ, Fang WH, Papadopoulos N, Jen J, de la Chapelle A, Kinzler KW, Vogelstein B, Modrich P 1993 Hypermutability and mismatch repair deficiency in RER_tumor cells. Cell 75:1227-1236
29. Ferna ́ndez de Mattos S, Villalonga P, Clardy J, Lam EW 2008 FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells. Mol Cancer Ther 7:3237-3246
30. Razandi M, Pedram A, Park ST, Levin ER 2003 Proximal events in signaling by plasma membrane estrogen receptors. J Biol Chem 278:2701-2712
31. Steffensen KR, Holter E, Båvner A, Nilsson M, Pelto-Huikko M, Tomarev S, Treuter E 2004 Functional conservation of interactions between a homeodomain cofactor and a mammalian FTZ-F1 homologue. EMBO Rep 5:613-619
32. Lee S, Kang J, Yoo J, Ganesan SK, Cook SC, Aguilar B, Ramu S, Lee J, Hong YK 2009 Prox1 physically and functionally interacts with COUP-TFII to specify lymphatic endothelial cell fate. Blood 113: 1856-1859
33. Qin J, Gao DM, Jiang QF, Zhou Q, Kong YY, Wang Y, Xie YH 2004 Prospero-related homeobox (Prox1) is a corepressor of human liver receptor homolog-1 and suppresses the transcription of the cholesterol 7β-hydroxylase gene. Mol Endocrinol 18:2424-2439
34. Song KH, Li T, Chiang JY 2006 A Prospero-related homeodomain protein is a novel co-regulator of hepatocyte nuclear factor 4_ that regulates the cholesterol 7βhydroxylase gene. J Biol Chem 281: 10081-10088
35. Yamazaki T, Yoshimatsu Y, Morishita Y, Miyazono K, Watabe T 2009 COUP-TFII regulates the functions of Prox1 in lymphatic endothelial cells through direct interaction. Genes Cells 14:425-434
36. Terzić J, Grivennikov S, Karin E, Karin M 2010 Inflammation and colon cancer. Gastroenterology 138:2101-2114
37. Karin M, Greten FR 2005 NFβB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749-759
38. Rochette PJ, Bastien N, Lavoie J, Guérin SL, Drouin R 2005 SW480, a p53 double-mutant cell line retains proficiency for some p53 functions. J Mol Biol 352:44-57
39. Karlsson A, Deb-Basu D, Cherry A, Turner S, Ford J, Felsher DW 2003 Defective double-strand DNA break repair and chromosomal translocations by MYC overexpression. Proc Natl Acad Sci USA 100:9974-9979
40. Jin P, Lu XJ, Sheng JQ, Fu L, Meng XM, Wang X, Shi TP, Li SR, Rao J 2010 Estrogen stimulates the expression of mismatch repair gene hMLH1 in colonic epithelial cells. Cancer Prev Res (Phila) 3:910-916
41. Weige CC, Allred KF, Allred CD 2009 Estradiol alters cell growth in nonmalignant colonocytes and reduces the formation of preneoplastic lesions in the colon. Cancer Res 69:9118-9124
42. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR, Katzenellenbogen BS 2003 Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144:4562-4574
43. Lin CY, Ström A, Vega VB, Kong SL, Yeo AL, Thomsen JS, Chan WC, Doray B, Bangarusamy DK, Ramasamy A, Vergara LA, Tang S, Chong A, Bajic VB, Miller LD, Gustafsson JA, Liu ET 2004 Discovery of estrogen receptorα target genes and response elements in breast tumor cells. Genome Biol 5:R66
44. Soulez M, Parker MG 2001 Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling. J Mol Endocrinol 27:259-274
45. Lazennec G, Bresson D, Lucas A, Chauveau C, Vignon F 2001 ERβinhibits proliferation and invasion of breast cancer cells. Endocrinology 142:4120-4130
46. Martineti V, Picariello L, Tognarini I, Carbonell Sala S, Gozzini A, Azzari C, Mavilia C, Tanini A, Falchetti A, Fiorelli G, Tonelli F, Brandi ML 2005 ER_ is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components. Endocr Relat Cancer 12:455-469
47. Tremblay A, Giguere V 2001 Contribution of steroid receptor coactivator-1 and CREB binding protein in ligand-independent activity of estrogen receptor _. J Steroid Biochem Mol Biol 77:19-27.
48. Vivar OI, Zhao X, Saunier EF, Griffin C, Mayba OS, Tagliaferri M, Cohen I, Speed TP, Leitman DC 2010 Estrogen receptorβbinds to and regulates three distinct classes of target genes. J Biol Chem 285:22059-22066
49. Thomas RS, Sarwar N, Phoenix F, Coombes RC, Ali S 2008 Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptorβ activity. J Mol Endocrinol 40:173-184
50. Atanaskova N, Keshamouni VG, Krueger JS, Schwartz JA, Miller F, Reddy KB 2002 MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance. Oncogene 21:4000-4008
51. Harlow E, Lane D 1988 Antibodies: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press
52. Asham E, Shankar A, Loizidou M, Fredericks S, Miller K, Boulos PB, Burnstock G, Taylor I 2001 Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ET(A) receptor antagonism. Br J Cancer 85:1759-1763
53. Galbiati F, Volonte ́ D, Liu J, Capozza F, Frank PG, Zhu L, Pestell RG, Lisanti MP 2001 Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/ p21(WAF1/Cip1)-dependent mechanism. Mol Biol Cell 12:2229-2244
54. Zeng ZS, Shu WP, Cohen AM, Guillem JG 2002 Matrix metalloproteinase- 7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases. Clin Cancer Res 8:144-148
55. Gongoll S, Peters G, Mengel M, Piso P, Klempnauer J, Kreipe H, von Wasielewski R 2002 Prognostic significance of calcium-binding protein S100A4 in colorectal cancer. Gastroenterology 123: 1478-1484
56. Sun L, Fu BB, Liu DG 2005 Systemic delivery of full-length C/EBP_/liposome complex suppresses growth of human colon cancer in nude mice. Cell Res 15:770-776
57. Fujiya M, Watari J, Ashida T, Honda M, Tanabe H, Fujiki T, Saitoh Y, Kohgo Y 2001 Reduced expression of syndecan-1 affects metastatic potential and clinical outcome in patients with colorectal cancer. Jpn J Cancer Res 92:1074-1081
58. Herynk MH, Stoeltzing O, Reinmuth N, Parikh NU, Abounader R, Laterra J, Radinsky R, Ellis LM, Gallick GE 2003 Down-regulation of c-Met inhibits growth in the liver of human colorectal carcinoma cells. Cancer Res 63:2990-2996
59. Nishimura T, Andoh A, Inatomi O, Shioya M, Yagi Y, Tsujikawa T, Fujiyama Y 2008 Amphiregulin and epiregulin expression in neoplastic and inflammatory lesions in the colon. Oncol Rep 19: 105-110
60. Nittka S, Gü nther J, Ebisch C, Erbersdobler A, Neumaier M 2004 The human tumor suppressor CEACAM1 modulates apoptosis and is implicated in early colorectal tumorigenesis. Oncogene 23:9306-9313
61. Rooney PH, Boonsong A, McFadyen MC, McLeod HL, Cassidy J, Curran S, Murray GI 2004 The candidate oncogene ZNF217 is frequently amplified in colon cancer. J Pathol 204:282-288
62. Wang S, Liu H, Ren L, Pan Y, Zhang Y 2008 Inhibiting colorectal carcinoma growth and metastasis by blocking the expression of VEGF using RNA interference. Neoplasia 10:399-407
63. Zeelenberg IS, Ruuls-Van Stalle L, Roos E 2003 The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 63:3833-3839
64. Zeng M, Kikuchi H, Pino MS, Chung DC 2010 Hypoxia activates the K-ras proto-oncogene to stimulate angiogenesis and inhibit apoptosis in colon cancer cells. PLoS One 5:e10966